| scholarly article | Q13442814 |
| P50 | author | Pilar de Castro-Manglano | Q96186758 |
| P2093 | author name string | Azucena Díez-Suárez | |
| Cesar A Soutullo | |||
| María Vallejo-Valdivielso | |||
| Juan J Marín-Méndez | |||
| P2860 | cites work | Neuropsychological deficits in preschool as predictors of ADHD symptoms and academic achievement in late adolescence | Q37558126 |
| Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents | Q38343322 | ||
| Validation of a Spanish-language version of the ADHD Rating Scale IV in a Spanish sample | Q38675126 | ||
| Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder | Q38827483 | ||
| Parent-based diagnosis of ADHD is as accurate as a teacher-based diagnosis of ADHD. | Q39167894 | ||
| Preadolescent girls with attention-deficit/hyperactivity disorder: II. Neuropsychological performance in relation to subtypes and individual classification | Q39632501 | ||
| Diagnostic Classification of ADHD Versus Control: Support Vector Machine Classification Using Brief Neuropsychological Assessment | Q39732400 | ||
| Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment | Q39735203 | ||
| ADHD comorbidity findings from the MTA study: comparing comorbid subgroups | Q40723668 | ||
| A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder | Q42918747 | ||
| Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders | Q43059973 | ||
| Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder | Q43990359 | ||
| Stroop/reverse-Stroop interference in typical development and its relation to symptoms of ADHD. | Q44351794 | ||
| A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder | Q44640554 | ||
| European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder | Q44784040 | ||
| Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder | Q44892902 | ||
| A comprehensive assessment of memory, delay aversion, timing, inhibition, decision making and variability in attention deficit hyperactivity disorder: advancing beyond the three-pathway models | Q46323179 | ||
| Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders | Q46448301 | ||
| A developmental fMRI study of the Stroop color-word task | Q46840950 | ||
| Beyond the dual pathway model: evidence for the dissociation of timing, inhibitory, and delay-related impairments in attention-deficit/hyperactivity disorder | Q48216069 | ||
| Color-word matching stroop task: separating interference and response conflict | Q48693073 | ||
| Causal Heterogeneity in Attention-Deficit/Hyperactivity Disorder: Do We Need Neuropsychologically Impaired Subtypes? | Q22252509 | ||
| The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis | Q28143881 | ||
| Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis | Q28258187 | ||
| Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD | Q28301651 | ||
| Clinical symptoms and performance on the Continuous Performance Test in children with attention deficit hyperactivity disorder between subtypes: a natural follow-up study for 6 months | Q33876929 | ||
| Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us? | Q33919950 | ||
| Half a century of research on the Stroop effect: an integrative review | Q34021872 | ||
| Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations | Q34084462 | ||
| Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate | Q34095733 | ||
| Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options | Q34286130 | ||
| Meta-analysis of intellectual and neuropsychological test performance in attention-deficit/hyperactivity disorder | Q34338318 | ||
| Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review | Q34425633 | ||
| Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder | Q34459431 | ||
| Characterizing cognition in ADHD: beyond executive dysfunction | Q34491828 | ||
| How specific is a deficit of executive functioning for attention-deficit/hyperactivity disorder? | Q34543480 | ||
| Emotion dysregulation in attention deficit hyperactivity disorder | Q34803697 | ||
| Distinct neuropsychological subgroups in typically developing youth inform heterogeneity in children with ADHD. | Q35921816 | ||
| Reaction time variability in ADHD: a review | Q36233143 | ||
| Neuropsychological functioning in people with ADHD across the lifespan | Q36394484 | ||
| Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder. | Q36403699 | ||
| Predicting Methylphenidate Response in ADHD Using Machine Learning Approaches | Q36588674 | ||
| Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder | Q36679760 | ||
| Working memory capacity predicts effects of methylphenidate on reversal learning | Q37103313 | ||
| A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents. | Q37115696 | ||
| Anxiety and methylphenidate in attention deficit hyperactivity disorder: a double-blind placebo-drug trial. | Q50578431 | ||
| [Life-span development of stroop and reverse-Stroop interference measured using matching responses]. | Q50771972 | ||
| Executive functions in preschool children with externalizing behavior problems: a meta-analysis. | Q50905356 | ||
| Executive functions: performance-based measures and the behavior rating inventory of executive function (BRIEF) in adolescents with attention deficit/hyperactivity disorder (ADHD). | Q51873455 | ||
| Neuropsychological functioning in stimulant-naive boys with hyperkinetic disorder. | Q51926695 | ||
| The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. | Q51974782 | ||
| Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. | Q52033104 | ||
| Effect of anxiety on cognition, behavior, and stimulant response in ADHD. | Q52112767 | ||
| Attention-deficit/hyperactivity disorder | Q56095090 | ||
| How Informative Are Parent Reports of Attention-Deficit/Hyperactivity Disorder Symptoms for Assessing Outcome in Clinical Trials of Long-Acting Treatments? A Pooled Analysis of Parents' and Teachers' Reports | Q57400342 | ||
| Diagnostic efficiency of neuropsychological test scores for discriminating boys with and without attention deficit–hyperactivity disorder | Q57400498 | ||
| Predicting methylphenidate response in attention deficit hyperactivity disorder: A preliminary study | Q57435671 | ||
| Attention deficit hyperactivity disorder | Q61702356 | ||
| Convergence of the Child Behavior Checklist with structured interview-based psychiatric diagnoses of ADHD children with and without comorbidity | Q72619661 | ||
| Symptom profiles in children with ADHD: effects of comorbidity and gender | Q73529408 | ||
| Predicting methylphenidate response in children with ADHD: theoretical, empirical, and conceptual models | Q77309673 | ||
| Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder | Q79874492 | ||
| Differential Response to Methylphenidate in Inattentive and Combined Subtype ADHD | Q85830763 | ||
| Daily Symptom Profiles of Children With ADHD Treated With Modified-Release Methylphenidate | Q86026398 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | neuropsychology | Q3872 |
| P304 | page(s) | 160-171 | |
| P577 | publication date | 2019-12-31 | |
| P1433 | published in | Clinical Practice and Epidemiology in Mental Health | Q15762194 |
| P1476 | title | Clinical and Neuropsychological Predictors of Methylphenidate Response in Children and Adolescents with ADHD: A Naturalistic Follow-up Study in a Spanish Sample | |
| P478 | volume | 15 |
Search more.